Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepak M W Balak

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
The British Journal of Dermatology|August 25, 2018
Topical trifarotene: a new retinoidDeepak M W Balak
Clinical and Experimental Dermatology|August 31, 2024
Diagnosing scabies in a patient with skin of colour using the burrow ink testDeepak M W Balak, Daan Rauwerdink
The British Journal of Dermatology|May 16, 2022
Weighing in on weight-based secukinumab dosing for psoriasisDeepak M W Balak, Jo Lambert
Psoriasis (Auckland, N.Z.)|October 10, 2024
Do NSAIDs Trigger or Exacerbate Psoriasis? [Response to Letter]Deepak M W Balak, Enes Hajdarbegovic
The New England Journal of Medicine|May 26, 2017
Anti-Interleukin-31 Receptor A Antibody for Atopic DermatitisEnes Hajdarbegovic, Deepak M W Balak
The New England Journal of Medicine|February 8, 2019
More on Mu-Opioid Receptor Antagonists in PD-1 Blockade–Induced PruritusDeepak M W Balak, Enes Hajdarbegovic
The British Journal of Dermatology|August 23, 2022
Anti-interleukin-17A for pityriasis rubra pilaris: catching the psoriasis biologic waveDeepak M W Balak, Robert Rissmann
Psoriasis (Auckland, N.Z.)|December 15, 2021
Non-Alcoholic Fatty Liver Disease (NAFLD) in Patients with Psoriasis: A Review of the Hepatic Effects of Systemic TherapiesDeepak M W Balak, Stefano Piaserico, Ismail Kasujee
Nederlands Tijdschrift Voor Geneeskunde|September 11, 2024
[A man with pruritic papules]Daan J W Rauwerdink, Thijs Ruiken, Deepak M W Balak
Dermatology and Therapy|June 13, 2020
Long-term Safety of Oral Systemic Therapies for Psoriasis: A Comprehensive Review of the LiteratureDeepak M W Balak, Sascha Gerdes, Aurora Parodi, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
The British Journal of Dermatology|August 25, 2018
Topical trifarotene: a new retinoidDeepak M W Balak
Clinical and Experimental Dermatology|August 31, 2024
Diagnosing scabies in a patient with skin of colour using the burrow ink testDeepak M W Balak, Daan Rauwerdink
The British Journal of Dermatology|May 16, 2022
Weighing in on weight-based secukinumab dosing for psoriasisDeepak M W Balak, Jo Lambert
Psoriasis (Auckland, N.Z.)|October 10, 2024
Do NSAIDs Trigger or Exacerbate Psoriasis? [Response to Letter]Deepak M W Balak, Enes Hajdarbegovic
The New England Journal of Medicine|May 26, 2017
Anti-Interleukin-31 Receptor A Antibody for Atopic DermatitisEnes Hajdarbegovic, Deepak M W Balak
The New England Journal of Medicine|February 8, 2019
More on Mu-Opioid Receptor Antagonists in PD-1 Blockade–Induced PruritusDeepak M W Balak, Enes Hajdarbegovic
The British Journal of Dermatology|August 23, 2022
Anti-interleukin-17A for pityriasis rubra pilaris: catching the psoriasis biologic waveDeepak M W Balak, Robert Rissmann
Psoriasis (Auckland, N.Z.)|December 15, 2021
Non-Alcoholic Fatty Liver Disease (NAFLD) in Patients with Psoriasis: A Review of the Hepatic Effects of Systemic TherapiesDeepak M W Balak, Stefano Piaserico, Ismail Kasujee
Nederlands Tijdschrift Voor Geneeskunde|September 11, 2024
[A man with pruritic papules]Daan J W Rauwerdink, Thijs Ruiken, Deepak M W Balak
Dermatology and Therapy|June 13, 2020
Long-term Safety of Oral Systemic Therapies for Psoriasis: A Comprehensive Review of the LiteratureDeepak M W Balak, Sascha Gerdes, Aurora Parodi, et al.
Pageof 4